Cervical spine osteoradionecrosis presents years after head and neck RT with serious complications
Across 88 cervical osteoradionecrosis cases, median onset was five years after RT; 41% developed epidural abscess and only 39% recovered fully.
Across 88 cervical osteoradionecrosis cases, median onset was five years after RT; 41% developed epidural abscess and only 39% recovered fully.
A 31-year-old patient with quiescent lupus and DCIS completed hypofractionated whole-breast RT plus boost with only grade 1 acute dermatitis.
In 3,309 randomized patients, five-year ipsilateral breast recurrence was 1.0% with partial-breast irradiation versus 0.8% with whole-breast irradiation, without proven noninferiority.
ReCOG presents six clinical scenarios emphasizing individualized cumulative dose assessment, organ function, and situations where abdominal reirradiation should be withheld.
Across 134 NSCLC patients, proton therapy reduced modeled blood dose by 12% without significantly changing lymphocyte nadir versus photons.
Among 52 HPV-positive oropharyngeal cancer patients, SAVER observed no contralateral nodal failures at median 31 months while reducing parotid dose.
Among 1,251 patients, 67% receiving curative and 80% receiving palliative radiotherapy reported at least one high-burden concern.
Among 39 palliative bone radiotherapy studies, 33% omitted the pain metric and 51% omitted the recall period.
In a 23-trainee pilot, brief digital modules improved geriatric oncology knowledge and confidence, particularly in comprehensive geriatric assessment.
In ten central lung tumors, proton PBS reduced low-dose lung exposure versus VMAT, but some critical-organ doses were less robust.
In two NSCLC cohorts, severe lymphopenia predicted worse survival before matching, but the association was no longer significant after accounting for disease burden.
In 364 patients with advanced head and neck cancer, cisplatin/5-FU did not significantly improve 10-year survival over mitomycin/5-FU.
In 29 patients receiving BMX-001 with head and neck chemoradiotherapy, 41.4% developed grade 3 mucositis, without a randomized comparator.
At six months after 30-Gy minibeam irradiation, rats lacking mature T cells showed preserved brain structure despite greater early tissue reactions.
In 13 patients receiving spacer-assisted pancreatic proton therapy, 30.8% had grade 3 events and two-year local control was 38.2%.